YU62900A - Postupak za dobijanje inhibitora za tip 1 izmenjivača natrijum-vodonik - Google Patents

Postupak za dobijanje inhibitora za tip 1 izmenjivača natrijum-vodonik

Info

Publication number
YU62900A
YU62900A YU62900A YUP62900A YU62900A YU 62900 A YU62900 A YU 62900A YU 62900 A YU62900 A YU 62900A YU P62900 A YUP62900 A YU P62900A YU 62900 A YU62900 A YU 62900A
Authority
YU
Yugoslavia
Prior art keywords
inhibitor
exchanger type
preparing sodium
hydrogen exchanger
nhe
Prior art date
Application number
YU62900A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Norma Jacqueline Tom
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU62900A publication Critical patent/YU62900A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/10Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
YU62900A 1999-10-29 2000-10-16 Postupak za dobijanje inhibitora za tip 1 izmenjivača natrijum-vodonik YU62900A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16237799P 1999-10-29 1999-10-29

Publications (1)

Publication Number Publication Date
YU62900A true YU62900A (sh) 2003-08-29

Family

ID=22585372

Family Applications (1)

Application Number Title Priority Date Filing Date
YU62900A YU62900A (sh) 1999-10-29 2000-10-16 Postupak za dobijanje inhibitora za tip 1 izmenjivača natrijum-vodonik

Country Status (19)

Country Link
US (1) US6441176B1 (Direct)
EP (1) EP1101763A3 (Direct)
JP (1) JP3342475B2 (Direct)
KR (2) KR100449595B1 (Direct)
CN (1) CN1146557C (Direct)
AR (1) AR029188A1 (Direct)
AU (1) AU779106B2 (Direct)
BR (1) BR0005122A (Direct)
CA (1) CA2324640A1 (Direct)
CZ (1) CZ20004018A3 (Direct)
HU (1) HUP0004187A2 (Direct)
ID (1) ID27904A (Direct)
IL (1) IL139198A0 (Direct)
PL (1) PL343542A1 (Direct)
RU (1) RU2190605C2 (Direct)
TR (1) TR200003143A2 (Direct)
TW (1) TWI221152B (Direct)
YU (1) YU62900A (Direct)
ZA (1) ZA200006007B (Direct)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852733B2 (en) 2000-04-28 2005-02-08 Pfizer Inc. Sodium-hydrogen exchanger type 1 inhibitor
IL156220A0 (en) * 2001-01-31 2003-12-23 Pfizer Prod Inc Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
MXPA04004685A (es) * 2001-12-19 2004-08-12 Pfizer Prod Inc Procedimientos para preparar inhibidores de tipo-1 de intercambiador sodio-hidrogeno.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028381A (en) * 1975-05-05 1977-06-07 Ciba-Geigy Corporation Pyrazolobenzazepines
DE4226649A1 (de) * 1992-08-12 1994-02-17 Bayer Ag Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole
RU2009129C1 (ru) * 1991-12-16 1994-03-15 Центр по химии лекарственных средств Арилгидразоны 5,6,7,8-тетрагидрохинолиндионы-2,5, обладающие кардиотонической активностью
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates
KR20030078886A (ko) 1998-02-27 2003-10-08 화이자 프로덕츠 인크. 허혈 치료용 n-[(치환된 5원 트리아자 이불포화고리)카르보닐] 구아니딘 유도체
UA72002C2 (en) 1999-10-29 2005-01-17 Pfizer Prod Inc Inhibitors crystals of sodium-hydrogen exchange of 1 type, a method for the preparation thereof (variants), a pharmaceuticalcomposition based thereon and a method for the reduction of tissue damage

Also Published As

Publication number Publication date
HK1036057A1 (en) 2003-07-10
TR200003143A2 (tr) 2001-05-21
BR0005122A (pt) 2001-06-19
HU0004187D0 (Direct) 2001-01-29
CZ20004018A3 (cs) 2002-04-17
EP1101763A3 (en) 2002-04-24
JP3342475B2 (ja) 2002-11-11
EP1101763A2 (en) 2001-05-23
ID27904A (id) 2001-05-03
AU779106B2 (en) 2005-01-06
PL343542A1 (en) 2001-05-07
RU2190605C2 (ru) 2002-10-10
CN1295070A (zh) 2001-05-16
HUP0004187A2 (hu) 2002-11-28
ZA200006007B (en) 2002-04-26
US6441176B1 (en) 2002-08-27
KR100443851B1 (ko) 2004-08-11
CA2324640A1 (en) 2001-04-29
TWI221152B (en) 2004-09-21
AU6133300A (en) 2001-05-03
KR100449595B1 (ko) 2004-09-21
KR20010060211A (ko) 2001-07-06
JP2001158784A (ja) 2001-06-12
KR20030061767A (ko) 2003-07-22
AR029188A1 (es) 2003-06-18
IL139198A0 (en) 2001-11-25
CN1146557C (zh) 2004-04-21

Similar Documents

Publication Publication Date Title
EA200001129A2 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
CA2441313A1 (en) New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
CA2260337A1 (en) Therapeutic agents
NO992821L (no) Ketobenzamider som calpain-inhibitorer
MXPA02009706A (es) Metodo para sintesis de perindopril y sus sales farmaceuticamente aceptables.
NO20005454L (no) Nye hydroksyindoler, deres anvendelse som fosfodiesterase 4 inhibitorer og fremgangsmåte for fremstilling derav
JO2654B1 (en) Multiple aryl caroxa amides are useful as lipid - lowering agents
DE69818278D1 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung
PT883405E (pt) Inibidores de amidino-protease
WO2000005214A3 (en) Isoquinolines as urokinase inhibitors
BG104575A (en) Matrix metalloprotease inhibitors
AU2002210425A1 (en) Novel beta-amyloid inhibitors, method for producing the same and the use thereofas medicaments
ATE229800T1 (de) Guanidino proteiase inhibitoren
YU62900A (sh) Postupak za dobijanje inhibitora za tip 1 izmenjivača natrijum-vodonik
MY136181A (en) Farnesyltransferase inhibitors
FI20000553L (fi) Proteaasi-inhibiittoreina käyttökelpoisten 4-hydroksi-2-oksopyraanijohdannaisten valmistusmenetelmä
AP2002002651A0 (en) Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)
ES2185196T3 (es) Un procedimiento para la preparacion de tetraazamacrociclos.
AP2001002045A0 (en) FKBP inhibitors.
AP2002002493A0 (en) Sodium-hydrogen exchanger type 1 inhibitor crystals.
PL331330A1 (en) Method of obtaining derivatives of 3-pyroline-2-carboxylic acid
PT1276722E (pt) Inibidores de naftamidina-uroquinase
BG105252A (en) Isoquinolines as urokinase inhibitors
MX9709462A (es) Acrilonitrilos diheterociclicos como inhibidores de la proliferacion de celulas del musculo liso.
BG103321A (en) Method for the preparation of phenoxyphenylsulphonyl halogenides